SG Americas Securities LLC Buys New Position in agilon health, inc. (NYSE:AGL)

SG Americas Securities LLC bought a new stake in agilon health, inc. (NYSE:AGLFree Report) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund bought 23,415 shares of the company’s stock, valued at approximately $92,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Capital International Investors grew its holdings in shares of agilon health by 84.7% in the first quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock valued at $123,207,000 after purchasing an additional 9,263,296 shares in the last quarter. AQR Capital Management LLC boosted its position in agilon health by 3,338.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after buying an additional 1,316,990 shares during the period. Susquehanna Fundamental Investments LLC acquired a new position in shares of agilon health in the first quarter worth $2,975,000. Vanguard Group Inc. increased its position in shares of agilon health by 1.3% during the first quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock worth $176,582,000 after acquiring an additional 371,537 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in shares of agilon health during the second quarter worth $1,849,000.

Analyst Ratings Changes

AGL has been the subject of several analyst reports. Benchmark reissued a “buy” rating and set a $9.00 target price on shares of agilon health in a research note on Thursday, August 8th. Evercore ISI lowered their price objective on agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research report on Tuesday, October 8th. Royal Bank of Canada restated an “outperform” rating and set a $8.00 target price on shares of agilon health in a research note on Wednesday, August 7th. Bank of America downgraded shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price target for the company. in a research note on Wednesday, October 2nd. Finally, Deutsche Bank Aktiengesellschaft dropped their price objective on shares of agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a research report on Friday, August 9th. Two equities research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $8.03.

Read Our Latest Research Report on AGL

agilon health Stock Up 4.5 %

AGL opened at $2.70 on Tuesday. agilon health, inc. has a one year low of $2.58 and a one year high of $18.37. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.36 and a current ratio of 1.36. The stock has a market capitalization of $1.11 billion, a P/E ratio of -3.85 and a beta of 0.54. The business’s 50-day simple moving average is $3.58 and its 200-day simple moving average is $5.13.

agilon health (NYSE:AGLGet Free Report) last released its quarterly earnings results on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, hitting the consensus estimate of ($0.07). The company had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.56 billion. agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. The firm’s revenue was up 38.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.04) earnings per share. Analysts anticipate that agilon health, inc. will post -0.32 EPS for the current year.

Insider Activity at agilon health

In other agilon health news, CEO Steven Sell bought 20,000 shares of agilon health stock in a transaction dated Thursday, September 12th. The stock was acquired at an average cost of $3.36 per share, with a total value of $67,200.00. Following the completion of the acquisition, the chief executive officer now owns 67,590 shares of the company’s stock, valued at approximately $227,102.40. This represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 3.20% of the stock is owned by insiders.

agilon health Profile

(Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Recommended Stories

Want to see what other hedge funds are holding AGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for agilon health, inc. (NYSE:AGLFree Report).

Institutional Ownership by Quarter for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.